08/21/2014 – Biogen
Issued: 08/18/2014
Biogen BIIB:
1. In Tuesday’s (Aug. 12) live meeting, Biogen (then trading at approximately $322) was forecast as a buy at or above $319 for a tradable advance to $342 (or higher).
2. Friday’s (Aug. 15) Biogen session completed the $342 upside target where a majority of the above noted long position was exited.
3. The next important daily market top for Biogen is Tuesday, Aug. 19 (+/-1 day). Therefore, daily closes below $349 are the weaker position and will indicate a multi-day decline.
4. Any remaining long position should place a protective sell stop at $338. This stop will be moved higher if the market continues to confirm.
David Williams
Issued: 08/21/2014
Biogen BIIB:
1. Our previous Biogen report and live meeting indicated new long entry at $322 (or higher) for a tradable advance to $342 (or higher).
2. After completion of the $342 upside target our protective stop was raised to $338. This stop was hit in today’s session, completing a successful trade. Will message any further entry or indication in Biogen.
David Williams
CFTC RULE 4.41 – HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.